The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)

Inclusion Criteria: * Must be 12 years of age and older, of either sex, and of any race. * Must weigh at least 40 kg (88 lb). * Must be willing to give written informed consent and be able to adhere to dose and visit schedules. * Must have a clinical diagnosis of acute bacterial sinusitis. * Must be symptomatic at the Screening and Baseline Visits on the basis of subject assessments of major symptoms score. * Must have radiographic evidence of sinusitis on CT scans taken at Screening. * Must be in general good health and free of any clinically significant disease (other than sinusitis) that would interfere with the study schedule or procedures, or compromise the subject's safety. * A subject's clinical laboratory tests (hematology, blood chemistry, and urinalysis), vital signs, and electrocardiogram (ECG) recordings must be within normal limits or clinically acceptable to the investigator/qualified designee. Any test results that are questionable should be referred to the sponsor. * A female subject of child-bearing potential must have a negative serum pregnancy (beta-hCG) test at Screening. She must agree to use a medically accepted method of contraception throughout the entire study period. Postmenopausal women will be exempted from the use of contraception during the study. Documented absence of menses for at least 1 year will indicate that a female is postmenopausal. If a pre-menarche female subject begins menstruating during the study, a serum pregnancy test must be don…